Allianz Asset Management GmbH - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 215 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,099,025
-6.5%
254,854
-3.4%
0.01%
-16.7%
Q2 2023$3,313,705
+15.9%
263,830
+2.3%
0.01%
+20.0%
Q1 2023$2,859,313
-5.5%
257,828
+4.1%
0.01%
-16.7%
Q4 2022$3,024,502
+17.6%
247,707
+0.6%
0.01%
+20.0%
Q3 2022$2,571,000
+84.3%
246,274
+307.6%
0.01%
+400.0%
Q4 2020$1,395,000
+241.9%
60,425
+36.8%
0.00%0.0%
Q1 2020$408,000
-71.3%
44,166
-69.8%
0.00%0.0%
Q4 2019$1,424,000
+352.1%
146,237
+272.8%
0.00%
Q3 2019$315,000
-34.8%
39,226
+1.4%
0.00%
Q2 2019$483,000
-35.4%
38,689
-29.7%
0.00%
-100.0%
Q1 2019$748,000
+151.0%
55,010
+77.1%
0.00%
Q4 2018$298,000
-87.5%
31,065
-84.3%
0.00%
-100.0%
Q3 2018$2,393,000
-78.0%
197,921
-71.6%
0.00%
-81.8%
Q2 2018$10,901,000
-8.6%
697,890
-12.0%
0.01%0.0%
Q1 2018$11,925,000
+4.7%
792,898
+0.2%
0.01%
+22.2%
Q4 2017$11,386,000
+0.0%
791,260
+4.8%
0.01%
-10.0%
Q3 2017$11,381,000
+7538.3%
754,759
+6986.9%
0.01%
Q3 2015$149,000
-23.2%
10,650
-22.3%
0.00%
Q2 2015$194,000
-25.4%
13,710
-42.7%
0.00%
Q1 2015$260,000
-1.5%
23,940
-24.5%
0.00%
Q4 2014$264,000
+13.3%
31,700
-19.1%
0.00%
Q3 2014$233,00039,1900.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 22,790,134$182,777,0006.12%
Perceptive Advisors 24,609,700$197,369,0005.32%
SECTORAL ASSET MANAGEMENT INC 3,441,922$27,604,0004.76%
Palo Alto Investors LP 7,162,920$57,447,0003.83%
Avoro Capital Advisors LLC 11,100,000$89,022,0003.71%
SPHERA FUNDS MANAGEMENT LTD. 2,930,320$23,501,0003.63%
Ghost Tree Capital, LLC 1,705,000$13,674,0003.48%
Novo Holdings A/S 2,317,870$18,589,0003.18%
Copernicus Capital Management, LLC 335,000$2,687,0002.50%
Boxer Capital, LLC 2,325,000$18,647,0001.35%
View complete list of AMICUS THERAPEUTICS INC shareholders